Intravenous (IV) Methylnaltrexone (MNTX) in the Prevention of Post-Operative Ileus

NCT01367548 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Postoperative Ileus

Interventions

DRUG: IV Methylnaltrexone (MNTX)
DRUG: Placebo

Sponsor

Bausch Health Americas, Inc.